This impressive track record easily grabs the attention of the investment community. However, some open-minded investors ...

With market uncertainty rising, investors are favoring defensive ETFs. Healthcare, gold miners, and nuclear energy funds are among the top picks in 2025.

TMFM has underperformed its benchmark by 3-5% annually over various time horizons. Read more to see why I'm bearish on the ...

Israel Englander of Millennium Management bought 12.6 million shares of the iShares Bitcoin Trust, increasing his stake by ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Spire Wealth Management increased its position in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE – Free Report) by 24.7% in the 4th quarter, according to the company in its most recent disclosure with ...

Swiss biotech Bioversys AG shares started trading at 36.5 Swiss francs ($40.29) on the SIX Swiss Exchange on Friday, slightly up from the final price for its initial public offering (IPO) of 36 Swiss ...

Caprock Group LLC purchased a new position in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) in the 4th quarter, HoldingsChannel.com reports. The institutional investor purchased 3,344 ...

Detailed price information for Nasdaq Biotechnology Ishares ETF (IBB-Q) from The Globe and Mail including charting and trades.

The tit-for-tat tariffs ignite fears of a trade war, prompting investors to dump riskier assets and take a flight to safety.